Features of the course of COVID-19 in patients with comorbid pathology
Comorbidity is an important problem of modern medicine, the study of which is a priority for public health. According to the literature, the prevalence of comorbidity reaches a third of the population in some countries, while there is a tendency for an increase in the number of such patients in all...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2022-04-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/6810 |
| _version_ | 1797841909342797824 |
|---|---|
| author | M. M. Sharipova M. V. Ivkina A. N. Arkhangelskaia K. G. Gurevich I. V. Maev |
| author_facet | M. M. Sharipova M. V. Ivkina A. N. Arkhangelskaia K. G. Gurevich I. V. Maev |
| author_sort | M. M. Sharipova |
| collection | DOAJ |
| description | Comorbidity is an important problem of modern medicine, the study of which is a priority for public health. According to the literature, the prevalence of comorbidity reaches a third of the population in some countries, while there is a tendency for an increase in the number of such patients in all age groups. In the context of the COVID-19 pandemic, the presence of comorbidity in patients is a significant risk factor affecting the course and prognosis of a new coronavirus infection; at the same time, it is comorbid patients who belong to the most vulnerable group. The review presents data indicating a significant impact of comorbid pathologies on an increase in the number of complications and mortality; the most common combinations of diseases in patients with a new coronavirus infection were analyzed. There is an increase in the prevalence of comorbidity in all age groups, which dictates the need to develop an integrated interdisciplinary approach for such patients. The vast majority of clinical guidelines for the treatment of comorbidities in COVID-19 are mainly focused on individual diseases, which limits the use of these algorithms in comorbid patients. Due to the high risk of contracting a viral infection, as well as the frequent development of complications and mortality in comorbid patients, preventive measures should be focused simultaneously on two tasks: measures aimed at preventing infection with COVID-19 and compensating for comorbid pathology. In the case of SARS-CoV-2 infection, careful monitoring of such patients, most often in a hospital setting, is necessary in order to prevent complications and adverse outcomes. |
| first_indexed | 2024-04-09T16:39:04Z |
| format | Article |
| id | doaj.art-74b2aa45fb014d85830ead0073598376 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:39:04Z |
| publishDate | 2022-04-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-74b2aa45fb014d85830ead00735983762023-04-23T06:56:45ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902022-04-0106444910.21518/2079-701X-2022-16-6-44-496116Features of the course of COVID-19 in patients with comorbid pathologyM. M. Sharipova0M. V. Ivkina1A. N. Arkhangelskaia2K. G. Gurevich3I. V. Maev4Yevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryComorbidity is an important problem of modern medicine, the study of which is a priority for public health. According to the literature, the prevalence of comorbidity reaches a third of the population in some countries, while there is a tendency for an increase in the number of such patients in all age groups. In the context of the COVID-19 pandemic, the presence of comorbidity in patients is a significant risk factor affecting the course and prognosis of a new coronavirus infection; at the same time, it is comorbid patients who belong to the most vulnerable group. The review presents data indicating a significant impact of comorbid pathologies on an increase in the number of complications and mortality; the most common combinations of diseases in patients with a new coronavirus infection were analyzed. There is an increase in the prevalence of comorbidity in all age groups, which dictates the need to develop an integrated interdisciplinary approach for such patients. The vast majority of clinical guidelines for the treatment of comorbidities in COVID-19 are mainly focused on individual diseases, which limits the use of these algorithms in comorbid patients. Due to the high risk of contracting a viral infection, as well as the frequent development of complications and mortality in comorbid patients, preventive measures should be focused simultaneously on two tasks: measures aimed at preventing infection with COVID-19 and compensating for comorbid pathology. In the case of SARS-CoV-2 infection, careful monitoring of such patients, most often in a hospital setting, is necessary in order to prevent complications and adverse outcomes.https://www.med-sovet.pro/jour/article/view/6810covid-19comorbidityrisk factorcomplicationsmortality |
| spellingShingle | M. M. Sharipova M. V. Ivkina A. N. Arkhangelskaia K. G. Gurevich I. V. Maev Features of the course of COVID-19 in patients with comorbid pathology Медицинский совет covid-19 comorbidity risk factor complications mortality |
| title | Features of the course of COVID-19 in patients with comorbid pathology |
| title_full | Features of the course of COVID-19 in patients with comorbid pathology |
| title_fullStr | Features of the course of COVID-19 in patients with comorbid pathology |
| title_full_unstemmed | Features of the course of COVID-19 in patients with comorbid pathology |
| title_short | Features of the course of COVID-19 in patients with comorbid pathology |
| title_sort | features of the course of covid 19 in patients with comorbid pathology |
| topic | covid-19 comorbidity risk factor complications mortality |
| url | https://www.med-sovet.pro/jour/article/view/6810 |
| work_keys_str_mv | AT mmsharipova featuresofthecourseofcovid19inpatientswithcomorbidpathology AT mvivkina featuresofthecourseofcovid19inpatientswithcomorbidpathology AT anarkhangelskaia featuresofthecourseofcovid19inpatientswithcomorbidpathology AT kggurevich featuresofthecourseofcovid19inpatientswithcomorbidpathology AT ivmaev featuresofthecourseofcovid19inpatientswithcomorbidpathology |